BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 8, 2012
View Archived Issues
Radius Health scientists design novel SARMs
Read More
Roche presents new potential products to treat/prevent CMV infection
Read More
Biota Holdings presents novel antibacterials
Read More
Interferon-free combination therapy shows promise to treat chronic hepatitis C
Read More
Encouraging phase I data reported on candidate arthritis immunotherapy
Read More
Pretargeted radioimmunotherapy is safe, specific and fast in patients with colorectal tumors
Read More
Korean team discovers novel serum biomarker of ovarian carcinoma
Read More
Genocea Biosciences presents potential HSV-2 vaccine at ongoing conference
Read More
Proteostasis Therapeutics to collaborate with CFFT
Read More
Interim data reported from combination study in CF
Read More
Sunovion confirms upcoming availability of ciclesonide nasal aerosol
Read More
Iluvien gains U.K. marketing authorization
Read More
Aeterna Zentaris regains rights to perifosine
Read More
Galleon Pharmaceuticals reports phase I GAL-021 study results
Read More
FDA clears p53 image analysis algorithm
Read More
Alder BioPharmaceuticals launches phase I trial of mAb for migraine
Read More
German BfArM issues recommendation on Pliaglis MAA
Read More
Santen and Bayer Yakuhin enter copromotion agreement
Read More
First-in-human data disclosed on topical RNAi drug for ocular pain
Read More
New phase III study of Adcetris begins
Read More
Immunomic Therapeutics clear to launch phase I trial of Japanese red cedar allergy vaccine
Read More
New candidate drugs for tuberculosis designed at GSK
Read More
Investigation at Roche yields novel TWEAK-specific antibodies
Read More
Envoy Therapeutics receives second grant from Michael J. Fox Foundation
Read More
FDA extends PDUFA date for Marqibo NDA
Read More